Lucio Comai, PhD

Professor of Immunology and Immune Therapeutics and Gerontology

Image of Lucio Comai, PhD
Is this your profile? Click to edit

Overview

Dr. Comai received his Ph.D.in Biochemistry in 1990 from the University of California, Davis and completed his postdoctoral training at University of California, Berkeley. He joined the faculty of the Keck School of Medicine in 1995. The goal of his research program is to advance the understanding of the mechanisms underlying aging and nucleotide repeat expansion disorders with the aim to develop novel therapeutic approaches and more effective treatments to increase health-span and live a longer, healthier life.

Awards

  • USC Idea Empowered, 2013
  • Johnson & Johnson Translational Innovation Partnership, 2012
  • Fullbright Specialist, 2008
  • American Cancer Society Scholar, 2003
  • Zumberge Faculty Research and Innovation, 2008
  • Travel Award;International Union Against Cancer, 1998
  • 1991
     -: Damon Runyon Cancer Research Fund, 1991
     – 1994
  • Leukemia and Lymphoma Society Scholar Award, 1991
  • 1997
     -: Jastro Schield Graduate Fellowship, 1997
     – 1999

Research Funding

  • Small molecule therapeutics for myotonic dystrophy type 1
    NIH · R01NS126219 · Jan 15, 2023 – Dec 31, 2027 · Role: Principal Investigator
  • Development and validation of a cell-based assay system to identify novel therapeutics for C9ALS/FTD
    NIH · R21NS112950 · Apr 1, 2020 – Sep 30, 2021 · Role: Principal Investigator
  • A destabilizing mechanism of expanded trinucleotide repeats as a potential therapeutic strategy for myotonic dystrophy
    NIH · R03NS107724 · Mar 1, 2019 – Feb 28, 2021 · Role: Principal Investigator
  • Mechanism of Small Molecule Mediated Rescue of Myotonic Dystrophy
    NIH/NINDS · R01NS080547 · Apr 1, 2013 – Mar 31, 2019 · Role: Co-investigator
  • Identification of Therapeutic Small Molecules for Myotonic Dystrophy Type 1
    NIH · R21NS077722 · Sep 30, 2011 – Aug 31, 2014 · Role: Co-Principal Investigator
  • Role of the Werner syndrome protein complex in the metabolism of chromosome ends
    NIH · R01AG034156 · Apr 1, 2010 – Aug 31, 2016 · Role: Principal Investigator
  • Biochemical analyses of muscleblind complexes in myotonic dystrophy
    NIH · R01NS060839 · Feb 1, 2007 – Nov 30, 2014 · Role: Co-Principal Investigator
  • The Werner syndrome protein in CPT-induced DNA damage
    NIH · R01AG023873 · Jun 1, 2004 – May 31, 2010 · Role: Principal Investigator
  • Viral regulation of ribosomal RNA transcription
    NIH · R01GM053949 · Jan 1, 1998 – Aug 31, 2010 · Role: Principal Investigator
  • Ribosomal RNA Synthesis by RNA Polymerase I
    American Cancer Society · Jul 1, 1997 – Jun 30, 2006 · Role: Principal Investigator

Publications

  • Targeting CTP synthetase 1 to restore interferon induction and impede nucleotide synthesis in SARS-CoV-2 infection. mBio. 2025 06 11; 16(6):e0064925.. View in PubMed
  • Staggered immunization with mRNA vaccines encoding SARS-CoV-2 polymerase or spike antigens broadens the T cell epitope repertoire. Proc Natl Acad Sci U S A. 2024 12 03; 121(49):e2406332121.. View in PubMed
  • Differential Outcomes of Infection by Wild-Type SARS-CoV-2 and the B.1.617.2 and B.1.1.529 Variants of Concern in K18-hACE2 Transgenic Mice. Viruses. 2023 12 29; 16(1).. View in PubMed
  • Mbnl2 loss alters novel context processing and impairs object recognition memory. iScience. 2023 May 19; 26(5):106732.. View in PubMed
  • Potent NKT cell ligands overcome SARS-CoV-2 immune evasion to mitigate viral pathogenesis in mouse models. PLoS Pathog. 2023 03; 19(3):e1011240.. View in PubMed
  • Impedimetric Sensing: An Emerging Tool for Combating the COVID-19 Pandemic. Biosensors (Basel). 2023 Jan 30; 13(2).. View in PubMed
  • A GABA-receptor agonist reduces pneumonitis severity, viral load, and death rate in SARS-CoV-2-infected mice. Front Immunol. 2022; 13:1007955.. View in PubMed
  • SARS-CoV-2 couples evasion of inflammatory response to activated nucleotide synthesis. Proc Natl Acad Sci U S A. 2022 06 28; 119(26):e2122897119.. View in PubMed
  • Mbnl1 and Mbnl2 regulate brain structural integrity in mice. Commun Biol. 2021 11 30; 4(1):1342.. View in PubMed
  • WRN modulates translation by influencing nuclear mRNA export in HeLa cancer cells. BMC Mol Cell Biol. 2020 Oct 14; 21(1):71.. View in PubMed